*Result*: Large language models in nephrology: applications and challenges in chronic kidney disease management.
Original Publication: New York, N.Y. : M. Dekker, c1987-
Acad Emerg Med. 2025 Mar;32(3):327-339. (PMID: 39676165)
J Pers Med. 2023 Dec 04;13(12):. (PMID: 38138908)
Chem Sci. 2024 Dec 9;16(6):2514-2572. (PMID: 39829984)
Cureus. 2023 Nov 3;15(11):e48244. (PMID: 38054127)
Br J Psychiatry. 2024 Feb;224(2):33-35. (PMID: 37881016)
Nat Cancer. 2025 Aug;6(8):1337-1349. (PMID: 40481323)
Diabetes Care. 2025 Feb 01;48(2):185-192. (PMID: 39250109)
Stud Health Technol Inform. 2024 Jul 24;315:671-672. (PMID: 39049375)
BMJ Ment Health. 2023 Nov;26(1):. (PMID: 37949485)
Healthcare (Basel). 2024 Aug 05;12(15):. (PMID: 39120251)
Curr Opin Nephrol Hypertens. 2019 Mar;28(2):178-182. (PMID: 30652978)
Front Artif Intell. 2023 May 04;6:1169595. (PMID: 37215063)
Kidney Int Rep. 2023 May 26;8(8):1657-1659. (PMID: 37547515)
Acad Radiol. 2020 Jan;27(1):58-61. (PMID: 31818387)
Clin Kidney J. 2023 Jul 29;16(12):2314-2326. (PMID: 38046016)
J Med Internet Res. 2019 Nov 27;21(11):e15787. (PMID: 31774408)
Arthroscopy. 2025 Mar;41(3):547-556. (PMID: 39694303)
Asian J Psychiatr. 2023 Apr;82:103505. (PMID: 36791611)
Nurs Outlook. 2015 Mar-Apr;63(2):162-70. (PMID: 25771190)
Stud Health Technol Inform. 2024 Jul 24;315:729-730. (PMID: 39049402)
Arthroscopy. 2025 Mar;41(3):565-573.e6. (PMID: 39521391)
J Nurs Scholarsh. 2012 Jun;44(2):136-44. (PMID: 22551013)
Pak J Med Sci. 2024 May-Jun;40(5):933-938. (PMID: 38827868)
JAMA Intern Med. 2023 Jun 1;183(6):589-596. (PMID: 37115527)
Cureus. 2023 Aug 29;15(8):e44316. (PMID: 37779749)
Clin Exp Nephrol. 2024 May;28(5):465-469. (PMID: 38353783)
Medicina (Kaunas). 2024 Jan 13;60(1):. (PMID: 38256408)
JAMA Netw Open. 2023 Dec 1;6(12):e2340232. (PMID: 38039007)
BMJ Health Care Inform. 2024 Jul 20;31(1):. (PMID: 39032946)
World J Urol. 2024 Oct 29;42(1):600. (PMID: 39470812)
J Endourol. 2024 Nov;38(11):e1244-e1245. (PMID: 38832862)
J Am Med Inform Assoc. 2025 Mar 01;32(3):586-588. (PMID: 39836496)
Heliyon. 2024 Feb 15;10(4):e26297. (PMID: 38384518)
JMIR Med Educ. 2023 Jun 1;9:e48291. (PMID: 37261894)
Health Soc Care Community. 2019 Jul;27(4):e438-e448. (PMID: 30945392)
Lancet Glob Health. 2024 Mar;12(3):e342-e343. (PMID: 38365398)
J Med Internet Res. 2024 Jan 19;26:e53225. (PMID: 38241074)
Medicina (Kaunas). 2024 Mar 08;60(3):. (PMID: 38541171)
Open Heart. 2023 Nov;10(2):. (PMID: 37945282)
JAMA. 2025 Jan 28;333(4):319-328. (PMID: 39405325)
Therap Adv Gastroenterol. 2024 Feb 22;17:17562848241227031. (PMID: 38390029)
Neurosurgery. 2025 Jan 16;97(2):387-398. (PMID: 40662770)
J Am Med Inform Assoc. 2024 Nov 1;31(11):2660-2667. (PMID: 39178375)
BMJ Open. 2024 Mar 8;14(3):e079814. (PMID: 38458787)
J Ren Nutr. 2025 May;35(3):401-409. (PMID: 39864474)
J Med Internet Res. 2024 Nov 14;26:e64226. (PMID: 39541580)
*Further Information*
*Large language models (LLMs) represent a transformative advance in artificial intelligence, with growing potential to impact chronic kidney disease (CKD) management. CKD is a complex, highly prevalent condition requiring multifaceted care and substantial patient engagement. Recent developments in LLMs-including conversational AI, multimodal integration, and autonomous agents-offer novel opportunities to enhance patient education, streamline clinical documentation, and support decision-making across nephrology practice. Early reports suggest that LLMs can improve health literacy, facilitate adherence to complex treatment regimens, and reduce administrative burdens for clinicians. However, the rapid deployment of these technologies raises important challenges, including patient privacy, data security, model accuracy, algorithmic bias, and ethical accountability. Moreover, real-world evidence supporting the safety and effectiveness of LLMs in nephrology remains limited. Addressing these challenges will require rigorous validation, robust regulatory frameworks, and ongoing collaboration between clinicians, AI developers, and patients. As LLMs continue to evolve, future efforts should focus on the development of nephrology-specific models, prospective clinical trials, and strategies to ensure equitable and transparent implementation. If appropriately integrated, LLMs have the potential to reshape the landscape of CKD care and education, improving outcomes for patients and supporting the nephrology workforce in an era of increasing complexity.*